MedPath

Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation

Not Applicable
Completed
Conditions
Hemiparesis
Stroke
Registration Number
NCT03096262
Lead Sponsor
Johns Hopkins University
Brief Summary

The purpose of this study is to advance upper limb robot-mediated tele-rehabilitation for patients recovering from stroke by empowering them through active science participation. By varying the tasks' features and affordances of a platform that combines a low-cost haptic device on one hand, and an online citizen science platform on the other, investigators will evaluate different strategies for social telerehabilitation. the two fundamental modes of social interaction - competition and cooperation - in addition to a control condition. Specifically, citizen science activities will be performed by competing, cooperating, or isolated users, and their rehabilitation effectiveness examined. Such effectiveness will be measured by (i) participants' rehabilitation performance (inferred from sensorimotor data acquired through the platform and directly quantified by a supervising therapist); (ii) participants' motivations to contribute (measured through surveys administered online); and (iii) participants' emotional well-being and sense of self-esteem (measured through online surveys).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

For treatment group:

  • post-stroke hemiparesis >3 months
  • ability to stand or sit independently
  • sufficient cognitive skills to perform the exercises as demonstrated
  • full passive range of motion in the affected arm but limited active movement as determined by a upper extremity Fugl-Meyer score of <50/66
  • technical savvy and interest to use an internet platform

For control group:

(ii) no history of learning disabilities (iii) technical savvy and interest to use an internet platform

Exclusion Criteria

For treatment group:

  • visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect
  • medical comorbidity such as other neurological conditions (e.g. Parkinson's disease, brain tumor, epilepsy), or previous injury to the upper limb
  • pain in the upper limbs that prevents full passive range of motion to perform the exercises.

For control group:

  • visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect
  • any previous injury or medical condition that prevents full passive range of motion to perform the exercises.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility of the kinect motion capture platform to capture movement assessed by range of motion1 day

Range-of-motion measurements of the affected and unaffected arm using the kinect motion capture platform.

Feasibility of the kinect motion capture platform to capture workload assessed by NASA Task Load Index1 day

Assesses work load on five 7-point scales. A series of measures that capture workload. Each scale employs a visual analog scale that measures each of the domains. The domains are Mental Domain, Physical Demand, Temporal Demand, Performance, Effort and Frustration Level. Each scale domain and the Composite has a range from 0 to 100 with 100 being the highest indicator of workload.

Feasibility of the kinect motion capture platform usability assessed by the System usability scale1 day

Using a 10 item scale to assess the usability of the technology platform with stroke patients. The measure is scored on a 0-100 scale, a higher score means a better outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Matthew Bird

🇺🇸

Baltimore, Maryland, United States

Matthew Bird
🇺🇸Baltimore, Maryland, United States
Matthew Bird, MD
Contact
410-955-1347
mbird6@jhmi.edu
Matthew Bird, MA
Contact
410-955-1381
mbird6@jhmi.edu
Preeti Raghavan, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.